A Study to Evaluate Rucaparib in Combination With Nivolumab in Patients With Selected Solid Tumors (ARIES)

Clinical trial NCT03824704 · TERMINATED

Trial details

NCT number: NCT03824704
Sponsor: pharmaand GmbH
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Epithelial Ovarian Cancer Fallopian Tube Cancer Primary Peritoneal Carcinoma High Grade Serous Carcinoma Endometrioid Adenocarcinoma

Start date: 2019-08-23
Primary completion: 2020-08-24
Enrollment: 1

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.